FDA commissioner nomination
Executive Summary
The Senate Health Committee is understood to be planning a vote on FDA Acting Commissioner Lester Crawford's nomination to the permanent post for mid-May. The vote would come just over a month after an April 13 vote on Crawford was abruptly cancelled. At the time, committee staff said the cancellation was due to an eleventh-hour anonymous allegation about personal conduct that the leadership believed merited further investigation (1"The Pink Sheet" April 18, 2005, p. 4)...